Drop, drop, drop! 3160 yuan → 123.99 yuan! Executed from April 1st

The official website of Wuhan Municipal Medical Insurance Bureau announced that from April 1, the city’s non-profit medical institutions, military medical institutions stationed in Hubei and the city’s voluntary medical insurance designated social medical institutions will implement the first batch of coronary artery expansion in the province. Balloon collection continues to select results. The results showed that the selected 50 varieties of coronary dilation balloons were all within 1,000 yuan, with the lowest price dropping to 123 yuan. As a high-value consumable commonly used in coronary interventional therapy, after the “100 yuan” coronary stent landed in our city, the coronary dilation balloon has also entered the ranks of “100 yuan” in Wuhan. After the price reduction of such medical consumables for coronary balloon dilation catheters, it is expected that the overall cost of cardiovascular surgery patients in our city will be greatly reduced.

New varieties are added to the centralized procurement of high-value consumables

Medical high-value consumables mainly belong to medical specialty treatment materials, with relatively high prices and large consumption . Since January 1 last year, the results of the centralized procurement of coronary stents organized by the state have landed in Wuhan. The price of coronary stents dropped from an average price of 13,000 yuan to about 700 yuan, with an average drop of 94.6%. After the price of coronary stents has been greatly reduced, the price of coronary dilation balloons, which are also necessary consumables for percutaneous coronary intervention, is still relatively high. In this context, coronary balloon catheter consumables have quickly become a “hot variety” for centralized collection in various places.

From 3160 yuan to 123.99 yuan

In fact, as early as October 2020, Wuhan City officially implemented the first batch of coronary dilation balls in the province The results of the bag collection were selected, and 8 varieties were selected. At that time, compared with the lowest purchase price in the country, the selected coronary artery dilation balloon dropped by up to 96%. After the first-year purchase agreement for the selected product has expired, the relevant department will renew the contract for the product that has expired. The results show that the number of selected products has increased to 50 varieties, and the prices are all within 1,000 yuan. For example, the balloon dilatation catheter produced for Shenzhen Shunmei Medical Co., Ltd., the price of the selection is 123.99 yuan per piece; the reporter checked the previous public price of the product was 3160 yuan. The balloon dilation catheter produced by Shenzhen Yixinda Medical New Technology Co., Ltd. has a price of 194.5 yuan per piece. The price of this product was previously listed on the Internet at 2,370 yuan, and the price dropped by more than 90%.

On the 11th, the reporter consulted A clinician in the Cardiovascular Department of a tertiary hospital in our city. According to reports, in the past, it cost about 20,000 to 30,000 yuan to perform a coronary stent operation one by one. Now, after the state purchases coronary stents and coronary dilation balloons in large quantities, performing a coronary stent operation one by one can reduce the cost of coronary stenting. to two or three thousand dollars. According to reports, the selected results of this coronary artery dilation balloon collection and succession have landed in our city. For non-selected products with the same category and similar functions other than the selected results, the lowest price of the national provincial-level online platform will be linked simultaneously, and not higher than The highest selected price of the selected products in this centralized purchase with quantity. It can be said that “following the coronary stent, the coronary dilation balloon has officially entered the ‘100 yuan era'”.

Wuhan will continue to explore the reform of high-value medical consumables

In recent years, Wuhan City has been increasing the consumption of consumables, reducing inflated prices, reducing overuse, Actively explore the reform of high-value medical consumables in terms of volume procurement. Since 2019, Wuhan City has fully implemented the cancellation of the markup on medical consumables in public medical institutions, and implemented “zero-markup” sales at the actual purchase price. “Let the prescription of medicines and the use of medical consumables such as stents and catheters no longer bring benefits to medical institutions.” In addition, the city has also launched a special campaign against fraud and insurance fraud in the field of high-value medical consumables.

In order to continue to promote the reform of high-value medical consumables, the 2022 Wuhan Municipal Government Work Report proposed that this year, the city will increase the centralized procurement of pharmaceutical consumables. At that time, “the burden on the masses will be further reduced”.

Central collection of high-value consumables for coronary interventional surgery

Wuhan timetable

▼< /p>

November 30, 2020

The first batch of coronary artery dilation balloons in the province was selected and landed in Wuhan, with a maximum drop of 96%.

January 1, 2021

The results of the national coronary stent centralized procurement were implemented in Wuhan, with an average decrease of 94.8%.

April 1, 2022

The first batch of coronary artery dilation balloons in the province was selected for continuous collection and landed in Wuhan, officially entering the “hundred yuan” era.

(produced by Changjiang Daily, written by reporter Hu Qiongzhi, drawn by Wang Yuzhe, produced by Cao Xinyi)

[Editor: Yao Hao]